AAAAAA

   
Results: 1-22 |
Results: 22
KW-2149 (7-N-[2-[GAMMA-L-GLUTAMYLAMINO]ETHYLDITHIO-ETHYL] MITOMYCIN-C) - DNA INTERACTIONS AND DRUG UPTAKE FOLLOWING SERUM ACTIVATION
Authors: MCADAM SR KNOX RJ HARTLEY JA MASTERS JRW
Citation: Sr. Mcadam et al., KW-2149 (7-N-[2-[GAMMA-L-GLUTAMYLAMINO]ETHYLDITHIO-ETHYL] MITOMYCIN-C) - DNA INTERACTIONS AND DRUG UPTAKE FOLLOWING SERUM ACTIVATION, Biochemical pharmacology, 55(11), 1998, pp. 1777-1783
COMPLEMENTATION ANALYSIS OF TESTIS TUMOR-CELLS
Authors: WANG XH HAFEZPARAST M MASTERS JRW
Citation: Xh. Wang et al., COMPLEMENTATION ANALYSIS OF TESTIS TUMOR-CELLS, Cancer genetics and cytogenetics, 98(1), 1997, pp. 56-62
DNA-REPAIR CAPACITY AND CISPLATIN SENSITIVITY OF HUMAN TESTIS TUMOR-CELLS
Authors: KOBERLE B GRIMALDI KA SUNTERS A HARTLEY JA KELLAND LR MASTERS JRW
Citation: B. Koberle et al., DNA-REPAIR CAPACITY AND CISPLATIN SENSITIVITY OF HUMAN TESTIS TUMOR-CELLS, International journal of cancer, 70(5), 1997, pp. 551-555
KW-2149 2-[Y-L-GLUTAMYLAMINO]ETHYLDITHIOETHYL]MITOMYCIN-C) - A NEW MITOMYCIN-C ANALOG ACTIVATED BY SERUM
Authors: MASTERS JRW KNOW RJ HARTLEY JA KELLAND LR HENDRIKS HR CONNORS T
Citation: Jrw. Masters et al., KW-2149 2-[Y-L-GLUTAMYLAMINO]ETHYLDITHIOETHYL]MITOMYCIN-C) - A NEW MITOMYCIN-C ANALOG ACTIVATED BY SERUM, Biochemical pharmacology, 53(3), 1997, pp. 279-285
THERMOTOLERANCE AND SENSITIVITY OF HUMAN CANCER-CELLS TO CISPLATIN AND DOXORUBICIN
Authors: RICHARDS EH BEGUM TA MASTERS JRW
Citation: Eh. Richards et al., THERMOTOLERANCE AND SENSITIVITY OF HUMAN CANCER-CELLS TO CISPLATIN AND DOXORUBICIN, International journal of oncology, 8(6), 1996, pp. 1265-1271
SENSITIVITY OF TESTIS TUMOR-CELLS TO CHEMOTHERAPEUTIC DRUGS - ROLE OFDETOXIFYING PATHWAYS
Authors: MASTERS JRW THOMAS R HALL AG HOGARTH L MATHESON EC CATTAN AR LOHRER H
Citation: Jrw. Masters et al., SENSITIVITY OF TESTIS TUMOR-CELLS TO CHEMOTHERAPEUTIC DRUGS - ROLE OFDETOXIFYING PATHWAYS, European journal of cancer, 32A(7), 1996, pp. 1248-1253
THIOTEPA PHARMACOKINETICS DURING INTRAVESICAL CHEMOTHERAPY - THE INFLUENCE OF DOSE AND VOLUME OF INSTILLATE ON SYSTEMIC UPTAKE AND DOSE-RATE TO THE TUMOR
Authors: MASTERS JRW MCDERMOTT BJ HARLAND S BIBBY MC LOADMAN PM
Citation: Jrw. Masters et al., THIOTEPA PHARMACOKINETICS DURING INTRAVESICAL CHEMOTHERAPY - THE INFLUENCE OF DOSE AND VOLUME OF INSTILLATE ON SYSTEMIC UPTAKE AND DOSE-RATE TO THE TUMOR, Cancer chemotherapy and pharmacology, 38(1), 1996, pp. 59-64
5-ALPHA-REDUCTASE EXPRESSION BY PROSTATE-CANCER CELL-LINES AND BENIGNPROSTATIC HYPERPLASIA IN-VITRO
Authors: SMITH CM BALLARD SA WORMAN N BUETTNER R MASTERS JRW
Citation: Cm. Smith et al., 5-ALPHA-REDUCTASE EXPRESSION BY PROSTATE-CANCER CELL-LINES AND BENIGNPROSTATIC HYPERPLASIA IN-VITRO, The Journal of clinical endocrinology and metabolism, 81(4), 1996, pp. 1361-1366
GENETIC-BASIS OF DRUG-SENSITIVITY IN HUMAN TESTIS TUMOR-CELLS
Authors: WANG XH HAFEZPARAST M MASTERS JRW
Citation: Xh. Wang et al., GENETIC-BASIS OF DRUG-SENSITIVITY IN HUMAN TESTIS TUMOR-CELLS, International journal of cancer, 65(4), 1996, pp. 426-431
RESPONSE TO EPIRUBICIN IN PATIENTS WITH SUPERFICIAL BLADDER-CANCER AND EXPRESSION OF THE TOPOISOMERASE-II ALPHA-GENE AND BETA-GENE
Authors: DAVIES SL POPERT R COPTCOAT M HICKSON ID MASTERS JRW
Citation: Sl. Davies et al., RESPONSE TO EPIRUBICIN IN PATIENTS WITH SUPERFICIAL BLADDER-CANCER AND EXPRESSION OF THE TOPOISOMERASE-II ALPHA-GENE AND BETA-GENE, International journal of cancer, 65(1), 1996, pp. 63-66
HYPERSENSITIVITY OF HUMAN TESTICULAR-TUMORS TO ETOPOSIDE-INDUCED APOPTOSIS IS ASSOCIATED WITH FUNCTIONAL P53 AND A HIGH BAX-BCL-2 RATIO
Authors: CHRESTA CM MASTERS JRW HICKMAN JA
Citation: Cm. Chresta et al., HYPERSENSITIVITY OF HUMAN TESTICULAR-TUMORS TO ETOPOSIDE-INDUCED APOPTOSIS IS ASSOCIATED WITH FUNCTIONAL P53 AND A HIGH BAX-BCL-2 RATIO, Cancer research, 56(8), 1996, pp. 1834-1841
EFFECT OF OVEREXPRESSION OF THE SMALL HEAT-SHOCK PROTEIN HSP27 ON THEHEAT AND DRUG SENSITIVITIES OF HUMAN TESTIS TUMOR-CELLS
Authors: RICHARDS EH HICKEY E WEBER L MASTERS JRW
Citation: Eh. Richards et al., EFFECT OF OVEREXPRESSION OF THE SMALL HEAT-SHOCK PROTEIN HSP27 ON THEHEAT AND DRUG SENSITIVITIES OF HUMAN TESTIS TUMOR-CELLS, Cancer research, 56(10), 1996, pp. 2446-2451
DOSE-RESPONSE STUDY OF SUPERFICIAL BLADDER-CANCER TO INTRAVESICAL ADMINISTRATION OF EPIRUBICIN
Authors: MASTERS JRW POPERT RJM GOODALL J COPTCOAT MJ PARMAR MKB
Citation: Jrw. Masters et al., DOSE-RESPONSE STUDY OF SUPERFICIAL BLADDER-CANCER TO INTRAVESICAL ADMINISTRATION OF EPIRUBICIN, British Journal of Cancer, 73(8), 1996, pp. 23-23
DNA-REPAIR IN CISPLATIN-SENSITIVE AND RESISTANT HUMAN CELL-LINES MEASURED IN SPECIFIC GENES BY QUANTITATIVE POLYMERASE CHAIN-REACTION
Authors: KOBERLE B PAYNE J GRIMALDI KA HARTLEY JA MASTERS JRW
Citation: B. Koberle et al., DNA-REPAIR IN CISPLATIN-SENSITIVE AND RESISTANT HUMAN CELL-LINES MEASURED IN SPECIFIC GENES BY QUANTITATIVE POLYMERASE CHAIN-REACTION, Biochemical pharmacology, 52(11), 1996, pp. 1729-1734
IMMORTALIZATION OF HUMAN UROTHELIAL CELLS
Authors: PETZOLDT JL LEIGH IM DUFFY PG SEXTON C MASTERS JRW
Citation: Jl. Petzoldt et al., IMMORTALIZATION OF HUMAN UROTHELIAL CELLS, Urological research, 23(6), 1995, pp. 377-380
RELATIVE CYTOTOXICITIES OF ADRIAMYCIN AND EPIRUBICIN IN COMBINATION WITH LONIDAMINE AGAINST HUMAN BLADDER-CANCER CELL-LINES
Authors: POPERT RJM MASTERS JRW COPTCOAT M ZUPI G
Citation: Rjm. Popert et al., RELATIVE CYTOTOXICITIES OF ADRIAMYCIN AND EPIRUBICIN IN COMBINATION WITH LONIDAMINE AGAINST HUMAN BLADDER-CANCER CELL-LINES, Urological research, 22(6), 1995, pp. 367-372
HEAT-SHOCK PROTEIN EXPRESSION IN TESTIS AND BLADDER-CANCER CELL-LINESEXHIBITING DIFFERENTIAL SENSITIVITY TO HEAT
Authors: RICHARDS EH HICKMAN JA MASTERS JRW
Citation: Eh. Richards et al., HEAT-SHOCK PROTEIN EXPRESSION IN TESTIS AND BLADDER-CANCER CELL-LINESEXHIBITING DIFFERENTIAL SENSITIVITY TO HEAT, British Journal of Cancer, 72(3), 1995, pp. 620-626
EXCEPTIONAL SENSITIVITY OF TESTICULAR GERM-CELL TUMOR-CELL LINES TO THE NEW ANTICANCER AGENT, TEMOZOLOMIDE
Authors: PERA MF KOBERLE B MASTERS JRW
Citation: Mf. Pera et al., EXCEPTIONAL SENSITIVITY OF TESTICULAR GERM-CELL TUMOR-CELL LINES TO THE NEW ANTICANCER AGENT, TEMOZOLOMIDE, British Journal of Cancer, 71(5), 1995, pp. 904-906
COMPARISON OF TESTOSTERONE-METABOLISM IN BENIGN PROSTATIC HYPERPLASIAAND HUMAN PROSTATE-CANCER CELL-LINES IN-VITRO
Authors: SMITH CM BALLARD SA WYLLIE MG MASTERS JRW
Citation: Cm. Smith et al., COMPARISON OF TESTOSTERONE-METABOLISM IN BENIGN PROSTATIC HYPERPLASIAAND HUMAN PROSTATE-CANCER CELL-LINES IN-VITRO, Journal of steroid biochemistry and molecular biology, 50(3-4), 1994, pp. 151-159
CULTURE AND CHARACTERIZATION OF HUMAN UROTHELIUM IN-VIVO AND IN-VITRO
Authors: PETZOLDT JL LEIGH IM DUFFY PG MASTERS JRW
Citation: Jl. Petzoldt et al., CULTURE AND CHARACTERIZATION OF HUMAN UROTHELIUM IN-VIVO AND IN-VITRO, Urological research, 22(2), 1994, pp. 67-74
SUPERFICIAL BLADDER-CANCER - THE RESPONSE OF A MARKER TUMOR TO A SINGLE INTRAVESICAL INSTILLATION OF EPIRUBICIN
Authors: POPERT RJM GOODALL J COPTCOAT MJ THOMPSON PM PARMAR MKB MASTERS JRW
Citation: Rjm. Popert et al., SUPERFICIAL BLADDER-CANCER - THE RESPONSE OF A MARKER TUMOR TO A SINGLE INTRAVESICAL INSTILLATION OF EPIRUBICIN, British Journal of Urology, 74(2), 1994, pp. 195-199
THE DIFFERENTIAL INDUCTION OF COLLATERAL RESISTANCE TO 62.5-MEV (P-]BE-MEV PHOTONS BY EXPOSURE TO CISPLATINUM() NEUTRONS AND 4)
Authors: BRITTEN RA WARENIUS HM MASTERS JRW PEACOCK JH BIOL CI
Citation: Ra. Britten et al., THE DIFFERENTIAL INDUCTION OF COLLATERAL RESISTANCE TO 62.5-MEV (P-]BE-MEV PHOTONS BY EXPOSURE TO CISPLATINUM() NEUTRONS AND 4), International journal of radiation oncology, biology, physics, 26(5), 1993, pp. 837-843
Risultati: 1-22 |